Delivery Order SPE2DB25D3201-SPE2DB25FNTCZ
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,109.89 firm fixed-price delivery order is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIALML, a medication. The contract has an ultimate completion date of May 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,021.25 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for the purchase of 4563575117...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,377.50 Firm Fixed Price delivery order is for the supply of GLYCOPYRROLATE INJECT, a medication used to treat certain conditions. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor and there is no set-aside designation. This award...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,254,915 units of the drug Glycopyrrolate 1 mg/5 ml vial, 5 ml, with a ceiling value of $1,495.28. It is a firm fixed-price delivery order contract with a completion date of September 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,663.89, is for the delivery of 4563500485 - GLYCOPYRROLATE 2ML 25S, a pharmaceutical product. The award has an ultimate completion date of February 28, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award, valued at $1,241.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glycopyrrolate 0.2 mg/ml vials (5 ml) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of glycopyrrolate 1 mg/5 ml vials, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order with a ceiling value of $2,172.95 and a completion date of March 21, 2025. The contract is not designated as a set-aside....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,252.97 firm-fixed-price delivery order is for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a completion date of August 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals....